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Background
Recent genome wide association studies (GWAS) of many
complex diseases have successfully identified novel sus-
ceptibility loci. An emerging observation is that a number
of loci are associated with more than one condition, par-
ticularly in the cases of autoimmune diseases.
In view of the shared pathology of adult inflammatory
arthritis and juvenile idiopathic arthritis (JIA) we hypoth-
esised that loci identified in GWAS of rheumatoid arthritis
(RA) may also have a role in JIA.
Aims
To test whether markers at three recently identified RA
susceptibility loci, STAT4, TRAF1/C5 and 6q23 region, are
also associated with JIA.
Methods
Previously associated SNPs for each of the three regions
(11 SNPs in total) were selected for investigation. Geno-
typing was performed using Sequenom MassArray. DNA
was available for 855 UK Caucasian JIA cases and 3599
controls. Genotype frequencies were compared between
cases and controls using the trend test implemented in
PLINK.
Results
Strong evidence for association was seen for both STAT4
(strongest effect rs7574865 OR 1.24 95%CI 1.1–1.4,
ptrend = 0.0008) and TRAF1/C5 (strongest effect
rs2900180 OR 1.23 95%CI 1.1–1.38, ptrend = 0.0004).
The 6q23 region showed weak evidence for association
with JIA (rs6920220 OR 1. 17 95% CI 1.01–1.36, ptrend
= 0.03). In all cases the associated allele was the same as
for RA and the effect sizes were similar.
Conclusion
We have identified three novel JIA susceptibility loci.
These findings are currently being validated in a North
American JIA cohort. Fine mapping and functional studies
will be required to elucidate how these polymorphisms
contribute to disease.
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